I find this article inflammatory in it's accusations, but....
...to get to the point, if this article is accurate and the vaccine was not completed, produced and given to physicians in West Africa for their patients because of profits, that is criminal.
I hope the vaccine goes forward as quickly as possible and I am sure the FDA will place it on fast track along without medical and transfusion remedies to Ebola.
It is a known fact vaccines in general are not widely produced and there is an Orphaned Drug Act. But, the FDA (click here) maintains an active interest in all rare diseases and their perhaps orphaned status. Given Ebola is a virus that can kill in a matter of a week when it's first symptoms arise, the vaccine should never be abandoned.
October 24, 2014
By Jonathan Benson
...Nearly a decade ago, (click here) researchers from Canada and the U.S. collaborated on the development of a vaccine for Ebola, which they tested on monkeys. Based on these tests, the vaccine was found to be 100 percent effective, and the results were published in the well respected journal Nature Medicine.
It was assumed at the time that the vaccine would be released commercially to stop the disease's spread in places like West Africa -- but it wasn't. The reason is that there was no profit to be made in releasing the vaccine at that time. Instead, Big Pharma decided to shelve the project until a later date when demand for the vaccine was higher, and more money could be made.
"Its development stalled in part because Ebola is rare and until now outbreaks had infected only a few hundred people at a time," explains The Boston Globe. "Most drug companies have resisted spending the enormous sums needed to develop products useful mostly to countries with little ability to pay."...
...to get to the point, if this article is accurate and the vaccine was not completed, produced and given to physicians in West Africa for their patients because of profits, that is criminal.
I hope the vaccine goes forward as quickly as possible and I am sure the FDA will place it on fast track along without medical and transfusion remedies to Ebola.
It is a known fact vaccines in general are not widely produced and there is an Orphaned Drug Act. But, the FDA (click here) maintains an active interest in all rare diseases and their perhaps orphaned status. Given Ebola is a virus that can kill in a matter of a week when it's first symptoms arise, the vaccine should never be abandoned.
October 24, 2014By Jonathan Benson
...Nearly a decade ago, (click here) researchers from Canada and the U.S. collaborated on the development of a vaccine for Ebola, which they tested on monkeys. Based on these tests, the vaccine was found to be 100 percent effective, and the results were published in the well respected journal Nature Medicine.
It was assumed at the time that the vaccine would be released commercially to stop the disease's spread in places like West Africa -- but it wasn't. The reason is that there was no profit to be made in releasing the vaccine at that time. Instead, Big Pharma decided to shelve the project until a later date when demand for the vaccine was higher, and more money could be made.
"Its development stalled in part because Ebola is rare and until now outbreaks had infected only a few hundred people at a time," explains The Boston Globe. "Most drug companies have resisted spending the enormous sums needed to develop products useful mostly to countries with little ability to pay."...
